Marco Montagna

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 10 papers. Top paper: “Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants”.

Characterization of the Cancer Spectrum in Men With GermlineBRCA1andBRCA2Pathogenic Variants

JAMA Oncology(2020)10.1001/jamaoncol.2020.2134

N/A

0.633DataRank · unranked

67 citations

Goska Leslie, Daniel R. Barnes, and the CIMBA Group, Bjarni A. Agnarsson, Kristiina Aittomäki +95 more

Common Breast Cancer Susceptibility Alleles and the Risk of Breast Cancer for BRCA1 and BRCA2 Mutation Carriers: Implications for Risk Prediction

UNC Libraries(2020)10.17615/bg56-kz70

N/A

0.449DataRank · unranked

19 citations

Trinidad Caldés, Maria A. Caligo, Alessandra Viel, Susan J. Ramus, Kathleen Claes +95 more

Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk

medRxiv(2024)10.1101/2024.02.29.24303243

N/A

0.208DataRank · unranked

3 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

UNC Libraries(2020)10.17615/dy70-ej71

N/A

0DataRank · unranked

0 citations

Kay‐Tee Khaw, Mark E. Robson, Diether Lambrechts, Janna Lilyquist, Emily Hallberg +95 more

Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants

Genetics in Medicine(2021)10.1016/j.gim.2021.08.016

N/A

0DataRank · unranked

30 citations

Christoph Engel, Miguel de la Hoya, Paolo Peterlongo, Drakoulis Yannoukakos, Luca Livraghi +56 more

Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

British Journal of Cancer(2023)10.1038/s41416-023-02263-5

N/A

0DataRank · unranked

19 citations

Susan J. Ramus, Melissa C. Southey, Nicola S. Meagher, Andreas Hadjisavvas, Esther M. John +87 more

Atypical cancer risk profile in carriers of Italian founder BRCA1 variant p.His1673del: Implications for classification and clinical management

Cancer Medicine(2024)10.1002/cam4.70114

N/A

0DataRank · unranked

3 citations

Cristina Fortuño, Laura Caleca, Bing Feng, Courtney Carroll, Michael T. Parsons +27 more

Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

npj Genomic Medicine(2025)10.1038/s41525-025-00529-w

N/A

0DataRank · unranked

0 citations

Jonathan P. Tyrer, Joe Dennis, Goska Leslie, Manjeet K. Bolla, Michael Lush +95 more

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing

UNC Libraries(2020)10.17615/kvd4-4s97

N/A

0DataRank · unranked

8 citations

James M. Flanagan, Hoda Anton‐Culver, Ellen L. Goode, Wendy R. Brewster, Matthias Dürst +95 more

Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA)

UNC Libraries(2020)10.17615/rh7v-bc86

N/A

0DataRank · unranked

2 citations

Fiona Lalloo, D. Stoppa-Lyonnet, N. Lindor, C. Casella, I. L. Andrulis +95 more